MedPath

Study of Red Bull™ Sugar-Free Drink for Reduction of Fatigue in Prostate Cancer Patients Receiving LHRH Agonist Therapy

Phase 2
Completed
Conditions
Fatigue
Interventions
Other: Red Bull™ Sugar-Free Drink
Registration Number
NCT01669460
Lead Sponsor
University Health Network, Toronto
Brief Summary

The purpose of this research study is to find out if Red Bull™ Sugar-Free Drink can reduce fatigue in prostate cancer patients receiving LHRH agonist therapy.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Male
Target Recruitment
20
Inclusion Criteria
  • Histologically confirmed prostate cancer
  • Currently receiving LHRH-agonist therapy for greater than 6 months
  • Measurable fatigue, defined as a score of ≥ 2 on the Bruera global fatigue severity scale
  • Able to swallow Red Bull™ Sugar-Free Drink
  • Life expectancy of at least 1 year
  • Able to read and write in English
  • Willing to limit consumption of alcohol to one drink per day
Read More
Exclusion Criteria
  • Current malignancy or received treatment for a previous malignancy within the last 3 years other than prostate cancer (exceptions are superficial bladder cancer or non-melanoma skin cancer)
  • Myocardial infarction within past 6 months
  • Any unstable serious co-existing medical condition(s) including but not limited to unstable or poorly controlled coronary artery disease, chronic atrial fibrillation, uncontrolled hypertension, uncontrolled diabetes, severe bleeding diseases or immune disorders
  • Evidence of drug or alcohol abuse
  • Known hypersensitivity to caffeine
  • Known history of liver and kidney insufficiencies
  • Known contraindications to Red Bull™ use
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Red Bull™ Sugar-Free DrinkRed Bull™ Sugar-Free DrinkRed Bull™ Sugar-Free Drink: two (250mL) cans per day for 28 days
Primary Outcome Measures
NameTimeMethod
Reduction in overall fatigue as measured by Bruera global fatigue severity scale.Within 4 days after completion of intervention (28 days of Red Bull™)
Secondary Outcome Measures
NameTimeMethod
Overall improvement in quality of life as measured by the Medical Outcomes Study Short-Form (SF-36)Within 4 days after completion of intervention (28 days of Red Bull™)

Trial Locations

Locations (1)

University Health Network

🇨🇦

Toronto, Ontario, Canada

© Copyright 2025. All Rights Reserved by MedPath